KRAS and cancer: Furthermore, machine‐learning algorithms applied to pan‐KRASG12C‐ and pan‐KRAS‐mutant cancer cell lines confirmed the superior predictive performance of subtype‐derived signatures for G12Ci sensitivity (Figures 3E and S8A).